<!DOCTYPE html>
<html manifest="manifest.manifest">
<head>
	<meta http-equiv=Content-Type content="text/html; charset=utf-8">
	<title>MRCG Clinical Guidelines</title>
	<meta name="viewport" content="width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=2.0, user-scalable=1">
  <meta name=Generator content="Microsoft Word 14 (filtered)">
		<link rel="stylesheet" href="jquery.mobile-1.4.5.min.css" />
	<link rel="stylesheet" href="mystyle.css" />
	<script src="jquery-1.11.1.min.js"></script>
	<script src="jquery.mobile-1.4.5.min.js"></script>
	<script type="text/javascript" src="cordova.js"></script>
	<script>
	    		$(function(){
			$("[data-role='header'], [data-role='footer']").toolbar();
		});
  	  $(document).one('pagebeforecreate', function () {
	        $('input[data-type="search"]').val("");
	    	        $.get("panel.html", function (data2) {
            $.mobile.pageContainer.prepend(data2);
              $("[data-role=panel]").panel().enhanceWithin();
        }, "html");
	           $.get("header.html", function (data) {
      $.mobile.pageContainer.prepend(data);
      $("[data-role='header']").toolbar().enhanceWithin();
    }, "html");
    $.get("footer.html", function (data) {
      $.mobile.pageContainer.append(data);
      $("[data-role='footer']").toolbar().enhanceWithin();
    }, "html");
        $('.WordSection1').wrap('<div role="main" class="ui-content">');
        $('table').wrap('<div class="tableCont"></div>');
        $('img').wrap('<div class="tableCont"></div>');
        $.mobile.pageContainer.enhanceWithin();
	  });
	        $(document).bind( "pagechange", function( ) {
        $('table').wrap('<div class="tableCont"></div>');
        $('img').wrap('<div class="tableCont"></div>');
        $('.tableCont').enhanceWithin();
      } );
			// When the user scrolls down 20px from the top of the document, show the button
		window.onscroll = function() {scrollFunction()};
		function scrollFunction() {
		  if (document.body.scrollTop > 20 || document.documentElement.scrollTop > 20) {
			document.getElementById("myBtn").style.display = "block";
		  } else {
			document.getElementById("myBtn").style.display = "none";
		  }
		}
		// When the user clicks on the button, scroll to the top of the document
		function topFunction() {
		  document.body.scrollTop = 0; // For Safari
		  document.documentElement.scrollTop = 0; // For Chrome, Firefox, IE and Opera
		}</script>      
</head>
<body lang=EN-GB link=blue vlink=purple>
	
<div data-role="page">
	<div role="main" class="ui-content">
<div class=WordSection1>
<h1><span lang=EN-US>Epilepsy</span></h1>
<h2><i><span lang=EN-US>Executive summary</span></i></h2>
<h2><span lang=EN-US>Introduction</span></h2>
<p class=MsoNormal><span lang=EN-US>Epilepsy is a chronic brain disorder
characterized by a predilection to having afebrile epileptic seizures. Most
epilepsy is of unknown cause (idiopathic epilepsy). Majority of people with
epilepsy live in LMICs like The Gambia. Epilepsy can significantly impair
quality of life and cause social stigma. Late presentation and poor adherence
to treatment increases the risk of status epilepticus and sudden unexpected
death in epilepsy (SUDEP). </span></p>
<p class=MsoNormal><span lang=EN-US>This guideline covers the diagnoses and
treatment of epilepsy and status epilepticus.</span></p>
<h3><span lang=EN-US style='font-size:12.0pt;text-decoration:none'>Target users</span></h3>
<p class=MsoListParagraphCxSpFirst style='margin-left:54.0pt;text-indent:-36.0pt'><span
lang=EN-US>•<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Nurses</span></p>
<p class=MsoListParagraphCxSpLast style='margin-left:54.0pt;text-indent:-36.0pt'><span
lang=EN-US>•<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Doctors</span></p>
<h3><span lang=EN-US style='font-size:12.0pt;text-decoration:none'>Target area
of use </span></h3>
<p class=MsoListParagraphCxSpFirst style='margin-left:54.0pt;text-indent:-36.0pt'><span
lang=EN-US>•<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Gate Clinic</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:54.0pt;text-indent:-36.0pt'><span
lang=EN-US>•<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Outpatient Department</span></p>
<p class=MsoListParagraphCxSpLast style='margin-left:54.0pt;text-indent:-36.0pt'><span
lang=EN-US>•<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Ward</span></p>
<h3><span lang=EN-US style='font-size:12.0pt;text-decoration:none'>Key areas of
focus / New additions / Changes </span></h3>
<p class=MsoNormal><span lang=EN-US>The diagnosis of epilepsy requires two <i>unprovoked</i>
epileptic seizures occurring at least 24 hours apart or a single <i>unprovoked </i>epileptic
seizure with an underlying predisposition to recurrence. Epileptic seizures are
classified based on onset, awareness and symptoms. The type of seizures and
other findings on clinical examination assist in the choice of drug therapy in
epilepsy.</span></p>
<p class=MsoNormal><span lang=EN-US>The diagnosis of epilepsy is clinical. EEG
may assist in classifying seizure type. Other investigations may be requested
to detect underlying causes or for monitoring patients on treatment.</span></p>
<p class=MsoNormal><span lang=EN-US>The goal of treatment is no seizures and no
side effects. Anticonvulsant monotherapy is preferred. Patients and their
caregivers should be involved in decision-making to improve adherence to drugs
and lifestyle measures prescribed.</span></p>
<p class=MsoNormal><span lang=EN-US>Special situations discussed include status
epilepticus, epilepsy in women of childbearing age including pregnancy,
patients with first unprovoked seizure, and non-epileptic seizures.</span></p>
<h3><span lang=EN-US style='font-size:12.0pt;text-decoration:none'>Limitations </span></h3>
<p class=MsoNormal><span lang=EN-US>EEG is not currently available in The
Gambia.</span></p>
<span lang=EN-US style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br
clear=all style='page-break-before:always'>
</span>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
lang=EN-US style='font-size:12.0pt'>&nbsp;</span></b></p>
<h2><span lang=EN-US>Presenting symptoms and signs</span></h2>
<h2><span lang=EN-US style='font-size:11.0pt;font-weight:normal'>An epileptic
seizure is a transient motor, sensory or psychic manifestation that results
from an abnormal paroxysmal electrical discharge in the brain. Presence of
epileptic seizures does not necessarily imply epilepsy is present as many acute
conditions can present with epileptic seizures as symptoms (acute symptomatic
seizures). However, significant brain injury from these conditions may
ultimately result in epilepsy (secondary or symptomatic epilepsy).</span></h2>
<h2><span lang=EN-US>Onset</span></h2>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Seizures may be focal in onset (one side of the
brain) or generalized (both sides of the brain). </span></p>
<p class=MsoListParagraphCxSpLast style='margin-left:72.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>Focal seizures may become secondarily generalized.
This initial focal component may be missed if eye-witnesses or the patient are
not specifically questioned. An “aura” preceding a generalized seizure is
considered a focal seizure. </span></p>
<h2><span lang=EN-US>Awareness</span></h2>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>In generalized seizures, the patient is
unconscious or has complete loss of awareness.</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Focal seizures may present  with intact
awareness (‘focal aware seizure”,  formerly called “simple partial seizure”) or
with impaired awareness.</span></p>
<h2><span lang=EN-US>Symptoms</span></h2>
<p class=MsoNormal><span lang=EN-US>Seizures may present as motor or non-motor
symptoms</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Focal motor seizures may present as abnormal
involuntary movements of the eyes, face, head or limbs; </span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Focal non-motor seizures may present as abnormal
sensations (strange odours, paraesthesia, abdominal pain) or as changes in cognition,
emotions or behaviour.</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Generalized motor seizures are most commonly
tonic-clonic but other forms including tonic, atonic, clonic and myoclonic
seizures may occur alone or in combination.</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Generalized non-motor seizures usually present
as absence seizures with brief episodes of loss of awareness. Automatisms may
be present but are not considered motor seizures.</span></p>
<h2><span lang=EN-US>Others</span></h2>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Seizures may occur alone, as part of a
recognizable epilepsy syndrome or as a component of a broader neurological
disorder.</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Not all seizure-like activities are epileptic in
nature; tics, tremors, spasms, non-epileptic myoclonus, syncope and psychogenic
non-epileptic seizures among many other conditions may mimic epileptic
seizures.</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>History should include questions about</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>Symptoms</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:108.0pt;text-indent:
-18.0pt'><span lang=EN-US style='font-family:Wingdings'>§<span
style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Warning
signs (“aura’) before episode</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:108.0pt;text-indent:
-18.0pt'><span lang=EN-US style='font-family:Wingdings'>§<span
style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Nature
of activity during episode</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:108.0pt;text-indent:
-18.0pt'><span lang=EN-US style='font-family:Wingdings'>§<span
style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Awareness
during episode and ability to recall after episode</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:108.0pt;text-indent:
-18.0pt'><span lang=EN-US style='font-family:Wingdings'>§<span
style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Patient’s
state and time to full recovery after episode</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:108.0pt;text-indent:
-18.0pt'><span lang=EN-US style='font-family:Wingdings'>§<span
style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Duration
and frequency of episodes</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:108.0pt;text-indent:
-18.0pt'><span lang=EN-US style='font-family:Wingdings'>§<span
style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Triggers</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:108.0pt;text-indent:
-18.0pt'><span lang=EN-US style='font-family:Wingdings'>§<span
style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Response
to any previous therapy</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>Prenatal, perinatal and developmental assessment.
</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>History of severe illness or severe head trauma</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>Ongoing drug use (illicit drugs,
anticonvulsants)</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>Consanguinity and family history of seizures.</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>There is room for uncertainty when describing
epilepsy in the absence of adequate information e.g generalized tonic-clonic
epilepsy with <i>unknown onset</i>, focal epilepsy, <i>awareness unknown</i>. </span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Eye-witness accounts and video recordings are
very helpful in diagnosis.</span></p>
<h2><span lang=EN-US>Examination findings</span></h2>
<p class=MsoNormal><span lang=EN-US>Examination of patients with epilepsy
should asses cardiac and neurological function, including mental status.
Examination of the skin may reveal abnormalities associated with some
neurological syndromes. Patients with generalized epilepsy may show signs of
past or recent trauma such as scars, bruises and lacerations.</span></p>
<h2><span lang=EN-US>Management </span></h2>
<p class=MsoNormal><b><u><span lang=EN-US>Diagnosis</span></u></b></p>
<p class=MsoNormal><span lang=EN-US>Diagnosis of epilepsy is based on clinical
findings. Investigations may be carried out to detect underlying causes and to
support the diagnosis where features are not typical.</span></p>
<p class=MsoNormal><span lang=EN-US>Video EEG is the gold standard for
classifying seizure types and detecting psychogenic non-epileptic seizures. It
is expensive and unavailable in our setting. </span></p>
<p class=MsoNormal><span lang=EN-US>Inter-ictal EEG can be done at Dakar, if
necessary. Inter-ictal EEG alone should not be used to differentiate epileptic
seizures from other diagnoses as false-positive findings can occur in persons
without epilepsy.</span></p>
<p class=MsoNormal><span lang=EN-US>CT scan or MRI can be requested if the
patient has abnormal neurologic findings. MRI is available in Dakar and may be
informative in patients with difficult-to-control focal-onset epilepsy. These
tests should not be routinely requested for patients with a clinical diagnosis
of idiopathic generalized epilepsy.</span></p>
<p class=MsoNormal><span lang=EN-US>Lumbar puncture for CSF analysis is useful
in patients with suspected meningitis, encephalitis, subarachnoid haemorrhage
or prolonged alteration in consciousness.</span></p>
<p class=numbered-paragraph style='margin-top:0cm;margin-right:0cm;margin-bottom:
9.0pt;margin-left:0cm;background:#FAFAFB'><span lang=EN-US style='font-size:
11.0pt;font-family:"Arial","sans-serif"'>Adults with suspected epilepsy should
have a standard electrocardiogram done. Young adults and children may also have
an ECG done if the diagnosis of epilepsy is uncertain. </span></p>
<p style='margin-top:0cm;margin-right:0cm;margin-bottom:9.0pt;margin-left:0cm;
line-height:18.0pt;background:#FAFAFB'><span lang=EN-US style='font-size:11.0pt;
font-family:"Arial","sans-serif"'>Adults with epilepsy should do the following
tests every 2 years:</span></p>
<p style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;margin-left:35.7pt;
margin-bottom:.0001pt;text-indent:-17.85pt;line-height:18.0pt;background:#FAFAFB'><span
lang=EN-US style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US style='font-size:11.0pt;font-family:"Arial","sans-serif"'>Full
blood count</span></p>
<p style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;margin-left:35.7pt;
margin-bottom:.0001pt;text-indent:-17.85pt;line-height:18.0pt;background:#FAFAFB'><span
lang=EN-US style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US style='font-size:11.0pt;font-family:"Arial","sans-serif"'>Electrolytes,
urea and creatinine, </span></p>
<p style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;margin-left:35.7pt;
margin-bottom:.0001pt;text-indent:-17.85pt;line-height:18.0pt;background:#FAFAFB'><span
lang=EN-US style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US style='font-size:11.0pt;font-family:"Arial","sans-serif"'>Liver
function tests</span></p>
<p style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;margin-left:35.7pt;
margin-bottom:.0001pt;text-indent:-17.85pt;line-height:18.0pt;background:#FAFAFB'><span
lang=EN-US style='font-size:11.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US style='font-size:11.0pt;font-family:"Arial","sans-serif"'>Serum
calcium</span></p>
<span lang=EN-US style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br
clear=all style='page-break-before:always'>
</span>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>
<p class=MsoNormal style='margin-top:6.0pt'><b><u><span lang=EN-US>Treatment</span></u></b></p>
<p class=MsoNormal><span lang=EN-US>Patients with suspected epilepsy should be
sent to the outpatient department for review by a doctor.</span></p>
<p class=MsoNormal><span lang=EN-US>The goal of epilepsy treatment is to stop
seizures completely without causing adverse effects from treatment (“no
seizures, no side-effects”). Studies have shown that this can be achieved in up
to 60% of patients. Up to 70% of patients remain seizure-free when medications
are discontinued after 2 - 5 years of treatment.</span></p>
<p class=MsoNormal><span lang=EN-US>To limit adverse events and drug
interactions, treatment with a single appropriate anticonvulsant drug is
preferred. Choosing this drug will require accurate classification of the type
of epilepsy and assessing its suitability for the particular patient. Patients
who remain uncontrolled on a single drug at maximum tolerated dose can have
another appropriate drug added to the regimen. The new drug should be titrated
to its maximum effective dose after which the old drug is tapered off
gradually.</span></p>
<p class=MsoNormal><span lang=EN-US>If the second drug is not helpful, any of
the two drugs can be tapered off first and then a third drug started. If
attempts at combination therapy are unhelpful, it is best to stay with the most
effective regimen tolerated by the patient.</span></p>
<p class=MsoNormal><span lang=EN-US>Lamotrigine and valproate are
broad-spectrum anticonvulsants but are best reserved for generalized onset
epilepsy. Valproate is notoriously teratogenic. It should be used by girls and
women of childbearing age only if there is no alternative on the condition that
they are counselled fully on the risk-benefit and the need for effective
contraception. Valproate is significantly more expensive than carbamazepine.
Lamotrigine is even more expensive.</span></p>
<p class=MsoNormal><span lang=EN-US>Epilepsy in adults is most commonly focal in
onset; this type of epilepsy generally responds to carbamazepine. Myoclonic
seizures and absence seizures may be worsened by carbamazepine and should be
treated with valproate.</span></p>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>
<div class="tableCont">
  <table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0 width="100%"
 style='width:100.0%;border-collapse:collapse;border:none'>
 <tr>
  <td width="24%" valign=top style='width:24.72%;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Epilepsy Syndrome</span></b></p>
  </td>
  <td width="43%" valign=top style='width:43.74%;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>First Line</span></b></p>
  </td>
  <td width="31%" valign=top style='width:31.54%;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Alternative / Adjunctive</span></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign=top style='width:24.72%;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Focal</span></p>
  </td>
  <td width="43%" valign=top style='width:43.74%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Carbamazepine</span></p>
  </td>
  <td width="31%" valign=top style='width:31.54%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Lamotrigine</span></p>
  <p class=MsoNormal><span lang=EN-US>Sodium valproate</span></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign=top style='width:24.72%;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Generalized tonic-clonic</span></p>
  </td>
  <td width="43%" valign=top style='width:43.74%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Sodium valproate</span></p>
  </td>
  <td width="31%" valign=top style='width:31.54%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Lamotrigine </span></p>
  <p class=MsoNormal><span lang=EN-US>Carbamazepine</span></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign=top style='width:24.72%;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Unclassified</span></p>
  </td>
  <td width="43%" valign=top style='width:43.74%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Sodium valproate</span></p>
  </td>
  <td width="31%" valign=top style='width:31.54%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Lamotrigine</span></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign=top style='width:24.72%;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Absence</span></p>
  </td>
  <td width="43%" valign=top style='width:43.74%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Ethosuximide (not readily available), </span></p>
  <p class=MsoNormal><span lang=EN-US>Sodium valproate</span></p>
  </td>
  <td width="31%" valign=top style='width:31.54%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Lamotrigine</span></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign=top style='width:24.72%;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Myoclonic </span></p>
  </td>
  <td width="43%" valign=top style='width:43.74%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Sodium valproate</span></p>
  </td>
  <td width="31%" valign=top style='width:31.54%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign=top style='width:24.72%;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Atonic or Tonic</span></p>
  </td>
  <td width="43%" valign=top style='width:43.74%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Sodium valproate</span></p>
  </td>
  <td width="31%" valign=top style='width:31.54%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign=top style='width:24.72%;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Infantile spasms</span></p>
  </td>
  <td width="43%" valign=top style='width:43.74%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Vigabatrin (not readily available), </span></p>
  <p class=MsoNormal><span lang=EN-US>ACTH (not readily available),</span></p>
  <p class=MsoNormal><span lang=EN-US>Prednisolone</span></p>
  </td>
  <td width="31%" valign=top style='width:31.54%;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
  </td>
 </tr>
</table>
</div>
<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
<p class=MsoNormal><span lang=EN-US>Discuss the nature of the diagnosis and
treatment with patient and caregivers. Lifestyle modifications and restrictions
should be discussed including hazards such as using dangerous equipment,
driving, working at heights, cooking over open flames and swimming. Drug
adherence and the risks associated with sudden drug discontinuation should be
emphasized.</span></p>
<p class=MsoNormal><span lang=EN-US>If the patient is seizure-free for 2 to 5
years, drug therapy can be tapered off over a 3-month period at least. For
patients on multiple drugs, discontinue one drug at a time. The risks of drug
discontinuation including the possibility of relapse should be discussed and a
clear plan agreed on with the patient.</span></p>
<p class=MsoNormal><b><u><span lang=EN-US>Special Situations</span></u></b></p>
<p class=MsoNormal><b><span lang=EN-US>Status Epilepticus:</span></b></p>
<p class=MsoNormal><span lang=EN-US>Generalized convulsive status epilepticus
is a life-threatening emergency. The typical patient with status epilepticus is
one who suddenly discontinued anti-epileptic medications. Structural and
metabolic disturbances can also lead to status epilepticus.</span></p>
<p class=MsoNormal><span lang=EN-US>Generalized convulsive status epilepticus
is diagnosed when:</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>A generalized tonic-clonic seizure lasts for
more than 5 minutes (Note that this period is for active fitting only and does
not include the post-ictal phase of sleep or confusion), <b>or</b></span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>A patient has a second generalized tonic-clonic
seizure without recovering fully from the first seizure. </span></p>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><i><span
lang=EN-US>Treatment:</span></i></b></p>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><i><span
lang=EN-US>1st stage (0&#8722;10 minutes)</span></i></p>
<p class=MsoListParagraphCxSpFirst style='margin-bottom:0cm;margin-bottom:.0001pt;
text-indent:-18.0pt'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Secure airway and resuscitate</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
.0001pt;text-indent:-18.0pt'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Administer oxygen</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
.0001pt;text-indent:-18.0pt'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Assess cardiorespiratory function</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
.0001pt;text-indent:-18.0pt'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Establish intravenous access </span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
.0001pt;text-indent:-18.0pt'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Administer glucose (50&nbsp;ml of 50% solution) in
adults (with intravenous thiamine 100&nbsp;mg if there is any feature
suggestive of alcoholism or malnutrition).</span></p>
<p class=MsoListParagraphCxSpLast style='margin-bottom:0cm;margin-bottom:.0001pt;
text-indent:-18.0pt'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Call the doctor on call</span></p>
<p class=MsoNormal style='margin-top:6.0pt;margin-right:0cm;margin-bottom:0cm;
margin-left:0cm;margin-bottom:.0001pt'><i><span lang=EN-US>2nd stage
(0&#8722;30 minutes)</span></i></p>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>Commence regular monitoring of vital signs</span></p>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>Send samples for emergency investigations</span></p>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>Consider the possibility of non-epileptic seizures</span></p>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>Emergency anticonvulsant therapy with IV diazepam </span></p>
<p class=MsoListParagraph style='margin-top:0cm;margin-right:0cm;margin-bottom:
0cm;margin-left:54.0pt;margin-bottom:.0001pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Give 0.15 mg/kg of IV diazepam over 5 minutes or
0.5 mg/kg PR (draw up the iv solution and use the syringe without an attached
needle to deliver the drug PR).</span></p>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>Give usual anti-epileptic medication via NG tube if already on treatment
for epilepsy.</span></p>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>Continue emergency anticonvulsant therapy with :</span></p>
<p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:54.0pt;margin-bottom:.0001pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Phenytoin infusion at a dose of 20 mg/kg at a
rate of 50&nbsp;mg/minute (do NOT mix with dextrose-containing infusion; use
normal saline).</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;margin-bottom:
.0001pt'><span lang=EN-US>OR</span></p>
<p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:54.0pt;margin-bottom:.0001pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>IV phenobarbital bolus of 15 mg/kg at a rate of
100&nbsp;mg/minute if phenytoin is unavailable.</span></p>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>Urethral catheterization</span></p>
<i><span lang=EN-US style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br
clear=all style='page-break-before:always'>
</span></i>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><i><span
lang=EN-US>&nbsp;</span></i></p>
<p class=MsoNormal style='margin-top:6.0pt;margin-right:0cm;margin-bottom:0cm;
margin-left:0cm;margin-bottom:.0001pt'><i><span lang=EN-US>3rd stage
(0&#8722;60 minutes)</span></i></p>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>Identify aetiology of status epilepticus and treat medical
complications.</span></p>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>If seizures persist 20 minutes after initial phenytoin infusion,
give additional 10 mg/kg of phenytoin infusion. </span></p>
<p class=MsoNormal style='margin-top:6.0pt;margin-right:0cm;margin-bottom:0cm;
margin-left:0cm;margin-bottom:.0001pt'><i><span lang=EN-US>4th stage
(30&#8722;90 minutes)</span></i></p>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>If still in status epilepticus 20 minutes after second phenytoin
infusion, give IV phenobarbital at 15 mg/kg.</span></p>
<p class=MsoNormal style='margin-top:6.0pt;margin-right:0cm;margin-bottom:0cm;
margin-left:0cm;margin-bottom:.0001pt'><i><span lang=EN-US>Emergency
investigations</span></i></p>
<p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:54.0pt;margin-bottom:.0001pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Blood glucose</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:54.0pt;margin-bottom:.0001pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Urinalysis</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:54.0pt;margin-bottom:.0001pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Serum electrolytes, urea and creatinine</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:54.0pt;margin-bottom:.0001pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Liver function tests</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:54.0pt;margin-bottom:.0001pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Serum calcium and magnesium</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:54.0pt;margin-bottom:.0001pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Full blood count </span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:54.0pt;margin-bottom:.0001pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Clotting profile</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:54.0pt;margin-bottom:.0001pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Chest radiograph may be needed to check for  possible
aspiration. </span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:54.0pt;margin-bottom:.0001pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Blood culture (if clinically indicated)</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:54.0pt;margin-bottom:.0001pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Cranial CT Scan (if clinically indicated)</span></p>
<p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:54.0pt;margin-bottom:.0001pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Lumbar puncture for CSF analysis (if clinically
indicated)</span></p>
<p class=MsoNormal style='margin-top:6.0pt'><span lang=EN-US>Ideally, patients
should have continuous EEG monitoring, toxicologic screening, arterial blood
gases and assay of anticonvulsant levels performed but these are not presently
feasible. </span></p>
<p class=MsoNormal><b><span lang=EN-US>Girls and women of child bearing age:</span></b></p>
<p class=MsoNormal><span lang=EN-US>Many anticonvulsant drugs reduce the
effectiveness of oral contraceptive pills. Other forms of contraception should
be recommended. </span></p>
<p class=MsoNormal><span lang=EN-US>Girls and women of childbearing age on
treatment for epilepsy should be prescribed 5 mg of folic acid daily.</span></p>
<p class=MsoNormal><span lang=EN-US>Anticonvulsant medications should not be
switched during pregnancy even when the mother is on sodium valproate.
Switching drugs increases the risks to both the mother and her fetus. Pregnant
patients with epilepsy should be referred to the obstetrician early in the
antenatal period.</span></p>
<p class=MsoNormal><b><span lang=EN-US>Patient with first unprovoked first
seizure:</span></b></p>
<p class=MsoNormal><span lang=EN-US>Although the risk of development of
epilepsy is higher in persons who have had a first unprovoked seizure, it is
recommended that anti-epileptic drugs be withheld until a second unprovoked
seizure occurs.</span></p>
<p class=MsoNormal><b><span lang=EN-US>Non-epileptic seizures:</span></b></p>
<p class=MsoNormal><span lang=EN-US>Some patients with psychological or
psychiatric problems may present with non-epileptic seizures (pseudoseizures,
psychogenic seizures). Other patients may produce seizure-like movements either
subconsciously (factitious disorder) or intentionally (malingering).</span></p>
<p class=MsoNormal><span lang=EN-US>Some of these patients actually have an
underlying epilepsy syndrome while others may have been misdiagnosed and
wrongly placed on epilepsy treatment. </span></p>
<p class=MsoNormal><span lang=EN-US>It is difficult to differentiate
non-epileptic seizures from true seizures without video-EEG monitoring.
However, presence of severe tongue biting, an ictal cry and incontinence makes
non-epileptic seizures unlikely.</span></p>
<p class=MsoNormal><span lang=EN-US>The following features are not definitive
but suggest a non-epileptic seizure especially when they occur together:</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Eyes closed during seizure and resistance to
passive eye-opening by examiner</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Patient’s hand fails to fall on face when
dropped over the head</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Side-to-side head movements during seizure</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Pelvic thrusts during seizure</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Seizures occurring with audiences (consulting
room, waiting room, ward rounds)</span></p>
<p class=MsoNormal><span lang=EN-US>Patients with suspected non-epileptic
seizures should do an EEG and undergo psychological evaluation. Maintain their
current therapy status until reviewed.</span></p>
<h2><span lang=EN-US>Key Issues for Nursing care</span></h2>
<h2 style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;margin-left:35.7pt;
margin-bottom:.0001pt;text-indent:-17.85pt'><span lang=EN-US style='font-size:
11.0pt;font-family:Symbol;font-weight:normal'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US style='font-size:11.0pt;font-weight:normal'>Monitor
closely and document seizures which may be subtle (e.g lip twitching)</span></h2>
<h2 style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;margin-left:35.7pt;
margin-bottom:.0001pt;text-indent:-17.85pt'><span lang=EN-US style='font-size:
11.0pt;font-family:Symbol;font-weight:normal'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US style='font-size:11.0pt;font-weight:normal'>Monitor
and document vital signs, fluids and level of consciousness</span></h2>
<p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:35.7pt;margin-bottom:.0001pt;text-indent:-17.85pt'><span
lang=EN-US style='font-size:12.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Nurse patients having generalized seizures in left
lateral position with bed rails raised up.</span></p>
<p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:35.7pt;margin-bottom:.0001pt;text-indent:-17.85pt'><span
lang=EN-US style='font-size:12.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Do not force any object between the teeth during
a seizure</span></p>
<h2><span lang=EN-US>References</span></h2>
<p class=MsoNormal><span style='font-size:10.0pt'>National Institute for Health
and Care Excellence. Epilepsies: diagnosis and management. Clinical guideline
[CG137]&nbsp;Published: January 2012&nbsp;Last updated:&nbsp;April 2018.
Available from: </span><span lang=EN-US><a
href="https://www.nice.org.uk/guidance/cg137"><span lang=EN-GB
style='font-size:10.0pt'>https://www.nice.org.uk/guidance/cg137</span></a></span><span
style='font-size:10.0pt'> Accessed: 11th November 2018</span></p>
<h1 style='margin-top:6.0pt;margin-right:0cm;margin-bottom:6.0pt;margin-left:
0cm;background:white'><span lang=EN-US><a
href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Devinsky%20O%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21386814"><span
lang=EN-GB style='font-size:10.0pt;color:windowtext;font-weight:normal;
text-decoration:none'>Devinsky O</span></a></span><span style='font-size:10.0pt;
font-weight:normal'>,&nbsp;<a
href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Gazzola%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21386814"><span
style='color:windowtext;text-decoration:none'>Gazzola D</span></a>,&nbsp;</span><span
lang=EN-US><a
href="https://www.ncbi.nlm.nih.gov/pubmed/?term=LaFrance%20WC%20Jr%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21386814"><span
lang=EN-GB style='font-size:10.0pt;color:windowtext;font-weight:normal;
text-decoration:none'>LaFrance WC Jr</span></a></span><span style='font-size:
10.0pt;font-weight:normal'>.</span><span style='font-size:10.0pt;font-weight:
normal'> Differentiating between nonepileptic and epileptic seizures. </span><span
lang=EN-US><a href="https://www.ncbi.nlm.nih.gov/pubmed/21386814"
title="Nature reviews. Neurology."><span lang=EN-GB style='font-size:10.0pt;
color:windowtext;font-weight:normal;text-decoration:none'>Nat Rev Neurol.</span></a></span><span
style='font-size:10.0pt;font-weight:normal'>&nbsp;2011 Apr;7(4):210-20. </span></h1>
<p class=MsoNormal><span lang=EN-US><a
href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Krumholz%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25901057"><span
lang=EN-GB style='font-size:10.0pt;color:windowtext;text-decoration:none'>Krumholz
A</span></a></span><span style='font-size:10.0pt'>,&nbsp;</span><span
lang=EN-US><a
href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Wiebe%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25901057"><span
lang=EN-GB style='font-size:10.0pt;color:windowtext;text-decoration:none'>Wiebe
S</span></a></span><span style='font-size:10.0pt'>,&nbsp;<a
href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Gronseth%20GS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25901057"><span
style='color:windowtext;text-decoration:none'>Gronseth GS</span></a>. Evidence-based
guideline: Management of an unprovoked first seizure in adults: Report of the
Guideline Development Subcommittee of the American Academy of Neurology and the
American Epilepsy Society. </span><span lang=EN-US><a
href="https://www.ncbi.nlm.nih.gov/pubmed/25901057" title=Neurology.><span
lang=EN-GB style='font-size:10.0pt;color:windowtext;text-decoration:none'>Neurology.</span></a></span><span
style='font-size:10.0pt'>&nbsp;2015 Apr 21;84(16):1705-13.</span></p>
<p class=MsoNormal><span style='font-size:10.0pt'>Medscape. Psychogenic
Nonepileptic Seizures. Available from: </span><span lang=EN-US><a
href="http://reference.medscape.com/article/1184694"><span lang=EN-GB
style='font-size:10.0pt'>http://reference.medscape.com/article/1184694</span></a></span><span
style='font-size:10.0pt'> Accessed: 30 November 2018</span></p>
<p class=MsoNormal><span style='font-size:10.0pt'>Medscape. Epilepsy and
Seizures. Available from: </span><span lang=EN-US><a
href="http://reference.medscape.com/article/1184846"><span lang=EN-GB
style='font-size:10.0pt'>http://reference.medscape.com/article/1184846</span></a></span><span
style='font-size:10.0pt'> Accessed: 25 November 2018 </span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>&nbsp;</span></p>
<div class="tableCont">
  <table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Written by:</span></b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Name: Fatai Akemokwe</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Date: 30 November 2018</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Reviewed by:</span></b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Name: Karen Forrest</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Date: 12 December 2018</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Version:</span></b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Change history:</span></b></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Review due date:</span></b></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>1.0</span></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>New document</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>31 January 2021</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>1.1</span></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Executive summary added</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>31 January 2021</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Review Comments (<i>if applicable)</i></span></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>&nbsp;</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>&nbsp;</span></b></p>
  </td>
 </tr>
</table>
</div>
<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
</div>
</div><!-- /content -->

</div>

</body>
</html>
